Mastodon

Vivacia Lipotropic Factors (Tablets) Instructions for Use

Marketing Authorization Holder

Artelar, LLC (Russia)

Manufactured By

Maryvery, Limited (UK)

Dosage Form

Bottle OTC Icon Vivacia Lipotropic Factors Tablets: 60 pcs.

Dosage Form, Packaging, and Product Composition

Tablets mass of 1560 mg.

1 dose (3 tab.)
Inositol 1000 mg
L-methionine 1000 mg
L-choline bitartrate 1000 mg

Auxiliary substances : volume-forming agent (microcrystalline cellulose), glazing agents (hydroxypropylmethylcellulose, calcium carbonate, polydextrose, medium chain triglycerides), anti-caking agent (magnesium stearate).

Nutritional value 100 g % RDI# 1 portion % RDI#
Proteins 0 g 0% 0 g 0%
Fats 0.1 g 0% 0 g 0%
Carbohydrates 41.2 g 16% 0.7 g 0%

# recommended norm of consumption.

Energy value (100 g): 742 kJ/177 kcal.

60 pcs. – bottles (1).

Therapeutic Category

Dietary supplement – additional source of amino acids

Indications

  • Vivacia Lipotropic Factors is indicated as a dietary supplement to provide nutritional support for individuals seeking an additional source of inositol, choline, and methionine.
  • It is intended for use as part of a balanced diet and healthy lifestyle to support general metabolic processes, particularly those involved in fat metabolism and liver function.
  • The product may be used by adults looking to supplement their nutritional intake with these specific lipotropic factors, which are compounds that help emulsify and metabolize fats.

Contraindications

  • Hypersensitivity to any of the components of the dietary supplement. Individuals with known allergies to the active or inactive ingredients should not use this product.
  • Patients with severe renal impairment or severe hepatic impairment should avoid use without medical supervision due to the potential for altered metabolism of the amino acid components.
  • Individuals with homocystinuria should not use this product due to the methionine content, which may exacerbate this condition.
  • Pregnancy and lactation: The safety of Vivacia Lipotropic Factors during pregnancy and breastfeeding has not been established. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before use.
  • Children and adolescents under the age of 18 years should not use this product unless specifically recommended by a healthcare professional.

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

The recommended adult dosage for Vivacia Lipotropic Factors is three tablets per day, taken orally with a full glass of water. For optimal absorption and to minimize potential gastrointestinal discomfort, the tablets should be taken with meals.

The duration of use should not exceed three consecutive months without consulting a healthcare professional. Do not exceed the recommended daily dosage, as higher intakes may increase the risk of adverse effects.

If you miss a dose, take it as soon as you remember, but if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose to make up for a missed one.

Drug Interactions

Vivacia Lipotropic Factors may interact with certain medications. Methionine can potentially interact with levodopa, potentially reducing its effectiveness in treating Parkinson’s disease. Patients taking levodopa should consult their physician before using this supplement.

The choline component may enhance the effects of acetylcholine esterase inhibitors and cholinergic agents, potentially leading to additive cholinergic effects. Caution is advised when using this supplement with medications that affect cholinergic transmission.

High doses of methionine may potentially affect the efficacy of certain antiepileptic drugs and may interact with drugs that affect homocysteine metabolism, such as folate, vitamin B6, and vitamin B12. Patients on these medications should exercise caution and seek medical advice.

As with any dietary supplement, inform your healthcare provider about all the products you are taking, including prescription drugs, over-the-counter medications, and other dietary supplements, to prevent potential interactions.

Adverse Reactions

Vivacia Lipotropic Factors are generally well-tolerated when taken at the recommended dosage. However, some individuals may experience gastrointestinal disturbances such as nausea, abdominal discomfort, diarrhea, or constipation. These effects are typically mild and often resolve with continued use or by taking the supplement with food.

In rare cases, some individuals may experience allergic reactions to the components of the supplement, which may manifest as skin rash, itching, or swelling. If any signs of allergic reaction occur, discontinue use immediately and seek medical attention.

High doses of methionine may potentially lead to increased homocysteine levels in susceptible individuals, which is a risk factor for cardiovascular issues. Individuals with pre-existing cardiovascular conditions should use this product with caution and under medical supervision.

If you experience any unexpected or severe symptoms while taking this supplement, discontinue use and consult your healthcare provider promptly. Report any adverse reactions to your pharmacist or physician.

Overdose

In case of accidental overdose of Vivacia Lipotropic Factors, seek immediate medical attention or contact a Poison Control Center. Symptoms of overdose may include severe gastrointestinal distress, nausea, vomiting, diarrhea, and in extreme cases, metabolic acidosis.

Methionine toxicity from excessive intake may manifest as neurological symptoms including confusion, disorientation, and lethargy. Very high doses may potentially lead to hyperhomocysteinemia, which is associated with increased cardiovascular risk.

There is no specific antidote for overdose of this dietary supplement. Treatment should be symptomatic and supportive. Do not induce vomiting unless directed by medical personnel. Provide the medical team with information about the product and the approximate amount ingested.

To prevent overdose, always adhere to the recommended dosage and keep the product out of reach of children. Store in a secure location to prevent accidental ingestion by children or pets.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS